Intensity TherapeuticsINTS
13F holders, Q4 2024 (December 31)20holders
2new positions
3sold out
1famous investor
$1.76avg. 13F price*
At the end of Q4 2024, 20 institutions reported holding Intensity Therapeutics Inc. (INTS) in their 13F filings, unchanged from Q3 2024. 2 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($2.0M), Sapient Capital LLC ($1.7M) and Vanguard Group Inc. ($370K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Intensity Therapeutics Inc.
- CUSIP
- 45828J103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2.0M |
| Exits | 3 | $125K |
All 13F filers, Q3 2024 → Q4 2024: 1,150,544 shares bought and 178,754 shares sold, net +971,790 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Armistice Capital, LLC | 0.05% | New | 1,126,868 | $2.0M |
| Sapient Capital LLC | 0.03% | Reduce -6.7% | 942,841 | $1.7M |
| Vanguard Group Inc. | 0.00% | No change | 208,886 | $370K |
| Brown Advisory Inc. | 0.00% | Reduce -12.2% | 130,072 | $229K |
| Geode Capital Management, LLC | 0.00% | No change | 64,349 | $114K |
| Sigma Planning Corp | 0.00% | Add +14.9% | 54,837 | $97K |
| Blair William & Co. | 0.00% | No change | 37,805 | $67K |
| One Charles Private Wealth Services, LLC | 0.02% | No change | 31,800 | $56K |
| BlackRock, Inc. | 0.00% | Add +0.6% | 22,252 | $39K |
| Mesirow Financial Investment Management, Inc. | 0.00% | Reduce -54.7% | 20,000 | $35K |
| GTS Securities LLC | 0.00% | Reduce -49.0% | 19,030 | $34K |
| Bison Wealth, LLC | 0.01% | No change | 17,420 | $31K |
| Citadel Advisors | 0.00% | New | 14,964 | $26K |
| State Street Corp. | 0.00% | No change | 14,500 | $26K |
| Stonebridge Financial Group, LLC | 0.00% | — | 8,301 | $15K |
| UBS Group AG | 0.00% | Reduce -85.3% | 3,021 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +126.5% | 2,648 | $5K |
| Morgan Stanley | 0.00% | No change | 500 | $880 |
| Bank of America Corp. | 0.00% | Add +2.0% | 50 | $88 |
| JPMorgan Chase & Co. | 0.00% | No change | 17 | $30 |
"% of holder's portfolio" is INTS's weight in each manager's 13F, not the share of Intensity Therapeutics Inc. the manager owns.